SCHEMBL8784222

SCHEMBL8784222

NCCc1c[nH]c2ccc(Cc3nnn(Cc4ccccc4)n3)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.58
HTR2C P28335 7/20 0.58
HTR1D P28221 2/20 0.49
HTR1B P28222 2/20 0.49
TRPM8 Q7Z2W7 3/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
LTA4H P09960 2/20 0.47
PLA2G2A P14555 2/20 0.47
SSTR4 P31391 3/20 0.47
HTR2A P28223 2/20 0.46
MPO P05164 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46
NFKB1 P19838 1/20 0.46
HTR7 P34969 1/20 0.46
CTSK P43235 1/20 0.46
HTR6 P50406 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8784127 0.82 HTR1A (0.76) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8784010 0.80 HTR1A (0.50) HTR1AHTR2CTRPM8LTA4HPLA2G2A
SCHEMBL31371849 0.79 HTR1A (0.67) HTR1AHTR2CHTR1DHTR1BTRPM8
SCHEMBL8746127 0.79 HTR1A (0.67) HTR1AHTR2CHTR1DHTR1BTRPM8
SCHEMBL8784321 0.79 HTR1A (0.58) HTR1AHTR2CHTR1DHTR1BTRPM8
SCHEMBL8746058 0.75 HTR1A (0.68) HTR1AHTR2CHTR1DHTR1BTRPM8
SCHEMBL8786045 0.74 HTR1A (0.88) HTR1AHTR2C
SCHEMBL8785674 0.74 HTR1A (0.88) HTR1AHTR2C
SCHEMBL8784514 0.74 HTR1A (1.00) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL4405605 0.72 HDAC6 (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP claimed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP claimed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP claimed
JP-5140151-A None JP disclosed
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP disclosed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP disclosed
US-5602163-A SELECTIVE AGONISTS OF 5-HYDROXYTRYPTAMINE RECEPTORS; USEFUL IN TREATMENT OF MIGRAINE HEADACHES MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5602162-A TREATMENT AND/OR PREVENTION OF MIGRAINE MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5451588-A Treatment of migraines MERCK SHARP & DOHME LTD. (GB) 1995-09-19 US disclosed
US-5298520-A Triazole containing indole derivatives MERCK SHARP & DOHME LIMITED (GB) 1994-03-29 US disclosed
JP-H05140151-A IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LTD 1993-06-08 JP disclosed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP disclosed